Homeopathy assuages side effects of Rx

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 18 No 5
Volume 18
Issue 5

Homeopathy can help cancer patients with skin irritation and mouth sores, according to a review involving 664 participants published in the Cochrane Database of Systematic Reviews (online issue 2, 2009).

Homeopathy can help cancer patients with skin irritation and mouth sores, according to a review involving 664 participants published in the Cochrane Database of Systematic Reviews (online issue 2, 2009).

Sosie Kassab, MD, director of the Royal London Homeopathic Hospital’s Complementary Cancer Service, and colleagues reviewed eight studies on homeopathic remedies.

In one study with 256 participants, researchers found skin irritation from radiotherapy was less in patients who used calendula ointment as opposed to the topical agent trolamine. In another study with 32 participants, the hemeopathic, Traumeel S, relieved mouth sores caused by chemotherapy better than placebo.

There is no convincing evidence to support the use of homeopathic medicines for adverse effects of cancer treatments other than skin irritation and mouth sores, Dr. Kassab said. “But very little research has been undertaken and more is required,” she said.

Most physicians are unaware that major, federally funded clinical trials on alternative medicine are currently underway (Arch Intern Med 169:670-679, 2009).

Recent Videos
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
Related Content